The accomplishments of Scott Rocklage in the biosciences field are quite remarkable, and are an inspiration in research or entrepreneurship. Dr. Rocklage has been working at 5AM Ventures since 2003 and is currently Managing Partner.
5AM is considered the go-to Venture Capital company for those in the life and biosciences field., and it’s all due to Rocklage’s leadership skills. Collaborative efforts with those using top notch scientific and medical advancements are the key to making new and exciting advancements happen, and Dr. Rocklage orchestrates these powerful components to make cutting edge technology a reality.
Dr. Rocklage says he’s most excited by the latest advancements in cancer treatment. There are now multiple ways of targeting specific genotypes and cancer mutations, increasing the chances of effective treatments along with extending and hopefully saving more lives. Rocklage has great expectations for the future as improvement on existing advancements will continue. Read more: Scott Racklage | Crunchbase
As it is with any Venture Capital firm, the key to developing successful ideas lies in risk management. Dr. Rocklage is certainly not afraid to make a calculated gamble on promising entrepreneurship, especially when the reward is far greater than the risk.
According to Rocklage, working for Fortune 500 companies is not necessarily a success measurement when the return could be exponentially greater putting those resources into an entrepreneurial environment that’s free of traditional best practices, R&D, and procurement standards that weigh large companies down.
This approach speaks for itself as Dr. Rocklage’s leadership has led to FDA approval of three new drug applications, Cubicin, Omniscan, and Teslascan. Additionally, Dr. Rocklage is inventor or co-inventor more than 30 patents and has published more than 100 peer-reviewed articles.
The Boston-based Scott Rocklage holds a Bachelor of Science degree from the University of California Berkley along with a PhD from the Massachusetts Institute of Technology (M.I.T).